1. The Finger Dexterity Test: Validation study of a smartphone-based manual dexterity assessment.
- Author
-
Van Laethem D, Denissen S, Costers L, Descamps A, Baijot J, Van Remoortel A, Van Merhaegen-Wieleman A, D'hooghe MB, D'Haeseleer M, Smeets D, Sima DM, Van Schependom J, and Nagels G
- Subjects
- Humans, Reproducibility of Results, Smartphone, Motor Skills, Upper Extremity, Fingers, Multiple Sclerosis diagnosis
- Abstract
Background: The Nine-Hole Peg Test (9HPT) is the golden standard to measure manual dexterity in people with multiple sclerosis (MS). However, administration requires trained personnel and dedicated time during a clinical visit., Objectives: The objective of this study is to validate a smartphone-based test for remote manual dexterity assessment, the ico mpanion Finger Dexterity Test (FDT), to be included into the ico mpanion application., Methods: A total of 65 MS and 81 healthy subjects were tested, and 20 healthy subjects were retested 2 weeks later., Results: The FDT significantly correlated with the 9HPT (dominant: ρ = 0.62, p < 0.001; non-dominant: ρ = 0.52, p < 0.001). MS subjects had significantly higher FDT scores than healthy subjects (dominant: p = 0.015; non-dominant: p = 0.013), which was not the case for the 9HPT. A significant correlation with age (dominant: ρ = 0.46, p < 0.001; non-dominant: ρ = 0.40, p = 0.002), Expanded Disability Status Scale (EDSS, dominant: ρ = 0.36, p = 0.005; non-dominant: ρ = 0.31, p = 0.024), and disease duration for the non-dominant hand (ρ = 0.31, p = 0.016) was observed. There was a good test-retest reliability in healthy subjects (dominant: r = 0.69, p = 0.001; non-dominant: r = 0.87, p < 0.001)., Conclusions: The ico mpanion FDT shows a moderate-to-good concurrent validity and test-retest reliability, differentiates between the MS subjects and healthy controls, and correlates with clinical parameters. This test can be implemented into routine MS care for remote follow-up of manual dexterity., Competing Interests: Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: D.V.L. is funded by a Fonds Wetenschappelijk Onderzoek (FWO) PhD fellowship (1SD5322N, https://www.fwo.be). S.D. prepares a PhD with icometrix as industrial partner, funded by a personal industrial PhD grant (Baekeland, HBC.2019.2579) appointed by Flanders Innovation and Entrepreneurship. J.B. has nothing to disclose. L.C. is an employee of icometrix. A.D. is an employee of icometrix. A.V.R. has nothing to disclose. A.V.M.-W. has nothing to disclose. M.B.D. has nothing to disclose. M.D. has nothing to disclose. D.S. is an employee and shareholder of icometrix. D.M.S. is an employee of icometrix. J.V.S. has nothing to disclose. G.N. is a minority shareholder of icometrix and a senior clinical research fellow of the FWO Flanders (1805620N, https://www.fwo.be).
- Published
- 2024
- Full Text
- View/download PDF